|
Market Closed -
Nasdaq
00:00:00 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 27.31 USD | -3.60% |
|
-31.98% | -65.48% |
| 11-12 | Analyst recommendations: Mastercard, Nvidia, Flex, Ge Aerospace… |  |
| 11-11 | Barclays Adjusts Price Target on Ionis Pharmaceuticals to $70 From $85, Keeps Overweight Rating | MT |
| Market Cap | 4.72B 4.27B 3.94B 3.56B 6.73B 444B 6.93B 47.25B 18.78B 237B 17.71B 17.33B 754B | P/E 2026 * |
-8.34x | P/E 2027 * | -10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 4.61B 4.17B 3.85B 3.49B 6.58B 434B 6.78B 46.2B 18.37B 232B 17.31B 16.94B 737B | EV / Sales 2026 * |
5.03x | EV / Sales 2027 * | 4.02x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Tradegate
| ISI | Real-time | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Xetra
| ISI | Delayed | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Borsa Italiana
| 1IONS | End-of-day quote |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -3.60% | ||
| 1 week | -31.98% | ||
| Current month | -37.25% | ||
| 1 month | -39.69% | ||
| 3 months | -50.72% | ||
| 6 months | -63.77% | ||
| Current year | -65.48% |
| 1 week | 27.28 |  | 40 |
| 1 month | 27.28 | | 45.84 |
| Current year | 27.28 | | 86.74 |
| 1 year | 27.28 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/16/26 A | Sell | Executive/Senior Manager | -53 | 0.0000% | ||
| 10/16/26 A | Sell | Head of Human Resources | -1,357 | 0.0008% | ||
| 8/31/26 A | Others | Chief Technology Officer | 110 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.60% | -31.98% | -62.31% | -41.09% | 4.72B | |
| +1.10% | +1.03% | +62.53% | +70.47% | 67.53B | |
| +1.28% | +8.79% | +16.26% | +95.16% | 60.74B | |
| +0.36% | +0.67% | +20.48% | +99.04% | 55.66B | |
| -0.96% | +10.11% | +21.04% | +108.91% | 47.97B | |
| -1.25% | +2.77% | +24.06% | +38.34% | 45.24B | |
| -2.41% | -11.69% | +175.20% | +794.72% | 39.08B | |
| +1.21% | +4.75% | +27.30% | +52.81% | 35.34B | |
| -0.87% | -1.34% | +83.95% | +63.96% | 33.45B | |
| -2.22% | +7.34% | -39.04% | +397.14% | 26.49B | |
| Average | -0.74% | -0.52% | +32.95% | +167.95% | 42B | |
| Weighted average by Cap. | -0.21% | +2.52% | +42.62% | +164.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 916M 829M 766M 692M 1.31B 86.19B 1.35B 9.18B 3.65B 46.1B 3.44B 3.37B 146B | 1.22B 1.11B 1.02B 925M 1.74B 115B 1.8B 12.26B 4.87B 61.57B 4.59B 4.5B 196B |
| Net income | -562M -509M -470M -425M -802M -52.88B -826M -5.63B -2.24B -28.29B -2.11B -2.07B -89.89B | -439M -397M -367M -332M -625M -41.26B -645M -4.39B -1.75B -22.07B -1.65B -1.61B -70.14B |
| Net Debt | -105M -94.83M -87.58M -79.2M -149M -9.86B -154M -1.05B -417M -5.27B -393M -385M -16.76B | 198M 179M 165M 150M 282M 18.63B 291M 1.98B 789M 9.97B 743M 728M 31.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | $27.31 | -3.60% | 6,195,671 |
| 11/11/26 | $28.33 | +0.50% | 6,552,104 |
| 10/11/26 | $28.19 | -9.06% | 10,692,785 |
| 09/11/26 | $31.00 | -21.36% | 19,508,605 |
| 06/11/26 | $39.42 | +1.60% | 2,911,840 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
